Protein profiles of exosomes (EXOs) in clinical samples of cancer patients have become a
promising diagnostic and therapeutic biomarker. However, simultaneous quantitative …

Exosomes (exos) widely existing in body fluids show great potential for noninvasive cancer
diagnosis. Quantitative analysis of exos is traditionally performed by targeting specific …

Breast cancer accounts for 11.6% of all cancer cases in both genders. Even though several
diagnostic techniques have been developed, the mostly used are invasive, complex, time …

Breast cancer subtypes have important implications of treatment responses and clinical
outcomes. Exosomes have been considered as promising biomarkers for liquid biopsies, but …

Cancer derived exosomal biomarkers (eg proteins, RNAs) could reflect important
information about the cancer microenvironment. For ultrasensitive analysis of exosomal …

Exosomes are a potential source of cancer biomarkers. Probing tumor-derived exosomes
can offer a potential non-invasive way to diagnose cancer, assess cancer progression, and …

Pancreatic cancer is a highly lethal malignancy. Lack of early diagnostic markers makes
timely detection of pancreatic cancer a highly challenging endeavor. Exosomes have …

The rapid development of exosome research provides new insights into the physiological
role of exosomes and their significant correlation with human health. Although the exosomes …

Due to the heterogeneity of breast cancer, its early accurate diagnosis remains a challenge.
Exosomes carry abundant genetic materials and proteins and are ideal biomarkers for early …

Exosomes, which are nanovesicles secreted by cells, are promising biomarkers for cancer
diagnosis and prognosis, based on their specific surface protein compositions. Here, we …